DEMEROL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Demerol, and what generic alternatives are available?
Demerol is a drug marketed by Hospira and Quagen and is included in two NDAs.
The generic ingredient in DEMEROL is meperidine hydrochloride. There are six drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the meperidine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Demerol
A generic version of DEMEROL was approved as meperidine hydrochloride by HIKMA on January 30th, 1985.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DEMEROL?
- What are the global sales for DEMEROL?
- What is Average Wholesale Price for DEMEROL?
Summary for DEMEROL
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 25 |
| Clinical Trials: | 11 |
| Patent Applications: | 4,227 |
| Drug Prices: | Drug price information for DEMEROL |
| What excipients (inactive ingredients) are in DEMEROL? | DEMEROL excipients list |
| DailyMed Link: | DEMEROL at DailyMed |
Recent Clinical Trials for DEMEROL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Centre hospitalier de l'Université de Montréal (CHUM) | Phase 3 |
| Monica Bhatia | Phase 1 |
| Ufuk University | Phase 4 |
Pharmacology for DEMEROL
| Drug Class | Opioid Agonist |
| Mechanism of Action | Full Opioid Agonists |
US Patents and Regulatory Information for DEMEROL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospira | DEMEROL | meperidine hydrochloride | INJECTABLE;INJECTION | 021171-001 | Approved Prior to Jan 1, 1982 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Quagen | DEMEROL | meperidine hydrochloride | INJECTABLE;INJECTION | 005010-009 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hospira | DEMEROL | meperidine hydrochloride | INJECTABLE;INJECTION | 021171-004 | Approved Prior to Jan 1, 1982 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Quagen | DEMEROL | meperidine hydrochloride | INJECTABLE;INJECTION | 005010-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hospira | DEMEROL | meperidine hydrochloride | INJECTABLE;INJECTION | 021171-002 | Approved Prior to Jan 1, 1982 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Hospira | DEMEROL | meperidine hydrochloride | INJECTABLE;INJECTION | 021171-003 | Approved Prior to Jan 1, 1982 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
